USE OF INHIBITORS OF PROTEIN KINASE C-ALPHA (PKC-ALPHA) ACTIVITY FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF DIABETIC RETINOPATHY, DIABETIC NEUROPATHY AND DIABETIC NEPHROPATHY

摘要

The invention relates to the use of agents impeding the expression and/or activity of protein kinase C alpha (PKC-), especially for treatment of patients with diabetes and complications such as diabetic nephropathy, retinopathy or neuropathy.